Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1–CBFβ interaction is a research paper published in Proceedings of the National Academy of Sciences (2012). On theSindex it has a DataRank of 0.738. It has been cited 136 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.738
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA140188
NIMH NIH HHS
Grant: X01MH083259-01
NIA NIH HHS
Grant: AG031300
NIA NIH HHS
Grant: K01 AG031300
NCI NIH HHS
Grant: CA140188
Intramural NIH HHS
Intramural NIH HHS
FWCI
3.95
Citation Percentile
0.9%
Influential Citations
11
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals